A Systematic Review and Meta-analysis of Randomized Controlled Trials of United States Food and Drug Administration-Approved, Home-use, Low-Level Light/Laser Therapy Devices for Pattern Hair Loss: Device Design and Technology.
Suparuj Lueangarun(Dhurakij Pundit University), Therdpong Tempark(Chulalongkorn University), Pollawat Jamparuang(Thammasat University), Poom Visutjindaporn(Thammasat University), Yardnapar Parcharoen(Thammasat University)
PubMed
November 1, 2021
Cited by 28
Related Papers
Green synthesis of metal nanoparticles, characterization, and biosensing applications
|Sensors International|2024|131
Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
|Dermatology and Therapy|2020|96
The 24‐hr, 28‐day, and 7‐day post‐moisturizing efficacy of ceramides 1, 3, 6‐II containing moisturizing cream compared with hydrophilic cream on skin dryness and barrier disruption in senile xerosis treatment
|Dermatologic Therapy|2019|38
Topical Botulinum Toxin Type A Liposomal Cream for Primary Axillary Hyperhidrosis: A Double-Blind, Randomized, Split-Site, Vehicle-Controlled Study
|Dermatologic Surgery|2018|30
Efficacy and safety of moisturizer containing 5% panthenol, madecassoside, and copper‐zinc‐manganese versus 0.02% triamcinolone acetonide cream in decreasing adverse reaction and downtime after ablative fractional carbon dioxide laser resurfacing: A split‐face, double‐blinded, randomized, controlled trial
|Journal of Cosmetic Dermatology|2019|26